Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Two immunodeficient children, aged 4 and 12 years, with crusted scabies were successfully treated with a single oral dose of ivermectin (200 micrograms/kg). One child had been diagnosed in infancy with an undefined congenital T cell immunodeficiency and the other with chronic mucocutaneous candidias...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1046/j.1440-0960.1999.00314.x
データ提供:米国国立医学図書館(NLM)
Crusted Scabies: A Case of Successful Ivermectin Treatment
This case report explores the successful treatment of crusted scabies, a severe form of scabies, in two immunocompromised children. The authors describe the challenges of conventional topical therapies in these patients and highlight the effectiveness of a single oral dose of ivermectin in achieving complete resolution of the condition. This case report underscores the potential role of ivermectin as a valuable therapeutic option for recalcitrant crusted scabies, particularly in immunocompromised individuals who may not respond to traditional treatments.
Navigating the Desert of Scabies
This research, like a journey through a harsh desert landscape, highlights the challenges of treating crusted scabies, especially in immunocompromised individuals. The study's successful use of ivermectin provides a beacon of hope for patients who have failed to respond to conventional therapies, offering a potential solution for this challenging condition. However, the authors emphasize the importance of careful consideration and appropriate medical guidance when using ivermectin, particularly in children and individuals with underlying health conditions.
A New Oasis for Scabies Treatment
This research provides valuable insights into the potential of ivermectin as a therapeutic option for recalcitrant crusted scabies, offering a glimmer of hope for patients who have struggled with conventional treatments. However, the study emphasizes the need for further research to fully understand the efficacy and safety of ivermectin in treating crusted scabies, particularly in immunocompromised individuals. The findings encourage a cautious and personalized approach to treatment, considering individual patient factors and potential risks.
Dr.Camel's Conclusion
This case report, like a camel navigating the treacherous sands of a desert, highlights the challenges and potential solutions for treating crusted scabies. The successful use of ivermectin in these immunocompromised children offers hope for patients who have faced difficulties with conventional therapies. The study emphasizes the importance of careful consideration and appropriate medical guidance when utilizing ivermectin, ensuring its safe and effective application in treating this often-difficult condition.
Date :
- Date Completed 1999-04-20
- Date Revised 2019-09-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.